Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
832
-
Total 13F shares, excl. options
-
227M
-
Shares change
-
-5.1M
-
Total reported value, excl. options
-
$43B
-
Value change
-
-$966M
-
Put/Call ratio
-
1.35
-
Number of buys
-
319
-
Number of sells
-
-409
-
Price
-
$189.88
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q3 2017
929 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q3 2017.
Elevance Health, Inc. - Common Stock (ELV) has 832 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 227M shares
.
Largest 10 shareholders include BlackRock Inc. (22.8M shares), VANGUARD GROUP INC (18M shares), PRICE T ROWE ASSOCIATES INC /MD/ (14.4M shares), STATE STREET CORP (11M shares), FMR LLC (9.95M shares), BAILLIE GIFFORD & CO (4.93M shares), WELLINGTON MANAGEMENT GROUP LLP (4.25M shares), NORDEA INVESTMENT MANAGEMENT AB (4.22M shares), Invesco Ltd. (4.16M shares), and GLENVIEW CAPITAL MANAGEMENT, LLC (3.8M shares).
This table shows the top 832 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.